Efficacy and Compliance of Loratadine Dry Syrup 1% in Pediatric Patients with Pruritic Skin Disease

2009 ◽  
Vol 71 (6) ◽  
pp. 616-623 ◽  
Author(s):  
Keizo MATSUO ◽  
Juichiro NAKAYAMA
2008 ◽  
Vol 70 (3) ◽  
pp. 308-312 ◽  
Author(s):  
Ryota TOKUMARU ◽  
Shinichi IMAFUKU ◽  
Juichiro NAKAYAMA

2012 ◽  
Vol 87 (5) ◽  
pp. 697-702 ◽  
Author(s):  
Magda Blessmann Weber ◽  
Daniel Lorenzini ◽  
Clarissa Prieto Herman Reinehr ◽  
Bárbara Lovato

BACKGROUND: Skin diseases cause negative impact on the emotional state, social relationships and daily activities, due to the stigma caused by the appearance of the lesions. OBJECTIVE: This study aimed to assess the quality of life of pediatric patients with skin diseases attending a dermatology service, compare the scores obtained among the dermatoses found in the sample and associate them to the variables, in addition to observing how the skin disease specifically affects quality of life. METHODS: Cross-sectional study, with patients between 5 and 16 years attending the Dermatology Service of the University of Health Sciences of Porto Alegre, Brazil, between July 2010 and February 2011. The data collection instruments were the Children's Dermatology Life Quality Index questionnaire and the AUEQI questionnaire. RESULTS: A total of 161 patients were interviewed, with mean age of 9,66 years. The main dermatoses were atopic dermatitis (29.8%), warts (13%) and molluscum contagiosum (7.5%). Chronic diseases (73.9%) were the most prevalent. The overall mean Children's Dermatology Life Quality Index score was 5.01 for chronic dermatoses and 2.07 for acute illnesses, indicating a compromised quality of life among chronically ill patients. The comparison between the scores obtained with the AUEQI scale and the Children's Dermatology Life Quality Index scores indicates that the overall quality of life is less affected than the specific quality of life related to the dermatosis. CONCLUSIONS: The data presented reinforce how important it is that the patients, their families and caregivers understand the symptoms, triggers and treatment of the skin disease in question. This information facilitates adherence to the treatment and justifies the conduct adopted by the dermatologist.


2004 ◽  
Vol 15 (s1) ◽  
pp. 59-59
Author(s):  
B. Skubic-Vengust ◽  
J. A. Hall ◽  
R. Reid-Smith ◽  
A. S. Peregrine

2007 ◽  
Vol 156 (6) ◽  
pp. 1235-1244 ◽  
Author(s):  
H. van Os-Medendorp ◽  
W.J.G. Ros ◽  
P.C.M. Eland-de Kok ◽  
C. Kennedy ◽  
B.H. Thio ◽  
...  

2019 ◽  
Vol 24 (9) ◽  
pp. 452-457
Author(s):  
Sue Paterson

Ectoparasite control forms an important part of any routine canine health programme but is also an integral part of the management of pruritic skin disease in the dog. As such it is important that veterinary surgeons are aware of the life cycle of the flea and the mode of action of the numerous flea control products that are currently available. The suitability of a product may be different depending on the health status of the dog and concurrent therapy. This article considers the most important groups of flea control products.


F1000Research ◽  
2015 ◽  
Vol 4 ◽  
pp. 1296 ◽  
Author(s):  
Michael Barton ◽  
Robert Sidbury

Atopic dermatitis is a chronic, pruritic skin disease characterized by an improperly functioning skin barrier and immune dysregulation. We review proposed atopic dermatitis pathomechanisms, emphasizing how these impact current perspectives on natural history, role of allergic sensitization, and future therapeutic targets.


Sign in / Sign up

Export Citation Format

Share Document